CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

Net Sales by Sales Format

Ordinary Income

Net Income

Business Results Data (Cons.)

Unit:million yen

    
  FY 2019 FY 2020 FY 2021 FY 2022 FY 2023(Est.)
Net Sales 10,843 10,830 11,698 12,257 12,537

Cost of Sales
(% of Net Sales)

5,615
51.8%
5,752
53.1%
6,438
55.0%
6,882
56.2%
6,884
54.9%

Gross Profit
(% of Net Sales)

5,228
48.2%
5,077
46.9%
5,260
45.0%
5,374
43.8%
5,654
45.1%

SG&A expenses
(% of Net Sales)

4,144
38.2%
4,092
37.8%
4,393
37.6%
4,636
37.8%
4,769
38.0%

Operating Income 
(% of Net Sales)

1,083
10.0%
984
9.1%
866
7.4%
737
6.0%
885
7.1%

Ordinary Income 
(% of Net Sales)

1,065
9.8%
952
8.8%
1,009
8.6%
809
6.6%
902
7.2%

Net Income
(% of Net Sales)

725
6.7%
659
6.1%
660
5.6%
460
3.8%
591
4.7%

Net Sales by Sales Format(cons.)

Unit:million yen

 
  FY 2019 FY 2020 FY 2021 FY 2022 FY 2023(Est.)

Own-brand
(%)

6,645
61.3%
6,640
61.3%
6,884
58.8%
6,986
57.0%
7,060
56.3%
Overseas
(%)
2,996
27.6%
2,943
27.2%
3,493
29.9%
3,930
32.1%
4,115
32.8%
OEM Sales
(%)
1,201
11.1%
1,245
11.5%
1,320
11.3%
1,340
10.9%
1,362
10.9%
Total
(%)
10,843
100.0%
10,830
100.0%
11,698
100.0%
12,257
100.0%
12,537
100.0%

Graph Showing Financial Position

Free Cash Flow

Financial Position Data(cons.)

Unit:million yen

  
  FY 2019 FY 2020 FY 2021 FY 2022 FY 2023(Est.)

Current Assets

11,129 10,722 11,575 12,128 12,712

Fixed Assets

6,028 6,374 6,500 6,736 5,985

Total Assets
(Gross Assets)

17,157 17,097 18,075 18,865 18,697

Current Liabilities

2,651 2,583 2,573 2,816 2,630

Fixed Liabilities

1,330 1,286 1,282 1,325 1,282

Total Liabilities

3,982 3,869 3,855 4,141 3,913

Shareholders' Equity

13,175 13,227 14,220 14,723 14,784

Equity Ratio

76.8% 77.4% 78.7% 78.0% 79.1%

Cash Flow Data

Unit:million yen

  FY 2019 FY 2020 FY 2021 Fy 2022 FY 2023
(Est.)

Net cash provided by (used in) operating activities

880 1,249 1,248 461 992

Net cash provided by (used in) investing activities

△ 511 △ 704 △ 585 38 △ 433

Net cash provided by (used in) financing activities

△ 532 △ 845 △ 442 △ 355 △ 336

Net increase in cash and cash equivalents

△ 203 △ 343 330 288 223

Cash and cash equivalents at end of year

3,426 3,083 3,413 3,702 3,920

Free Cash Flow

368 544 663 499 559
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2019 FY 2020 FY 2021 FY 2022 FY 2023(Est.)
ROE 5.6% 5.0% 4.8% 3.2% 4.0%
EPS(yen) 77.83 71.19 72.61 50.63 64.95
BPS(yen) 1,414.36 1,454.41 1,563.55 1,618.10 1,624.73

Dividend per Share (yen)

37 37 37 37 37

Dividend Payout Ratio(cons.)

47.5% 52.0% 51.0% 73.1% 57.0%

TOP